SSKN Financial Statements

Balance sheet, income statement, cash flow, and dividends for Strata Skin Sciences Inc (SSKN).


$12.14M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

SSKN Market Cap. (MRY)


SSKN Shares Outstanding (MRY)


SSKN Assets (MRY)


Total Assets

$36.16M

Total Liabilities

$31.18M

Total Investments

$0

SSKN Income (MRY)


Revenue

$33.56M

Net Income

-$10.09M

Operating Expense

$28.34M

SSKN Cash Flow (MRY)


CF Operations

$188.00K

CF Investing

-$1.64M

CF Financing

$1.93M

SSKN Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

SSKN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$36,157,000 (-13.94%)

$42,016,000 (-19.62%)

$52,272,000 (12.19%)

$46,593,000 (-0.40%)

Assets Current

$16,595,000 (6.77%)

$15,543,000 (-11.20%)

$17,504,000 (-12.35%)

$19,970,000 (-19.58%)

Assets Non-Current

$19,562,000 (-26.11%)

$26,473,000 (-23.86%)

$34,768,000 (30.59%)

$26,623,000 (21.31%)

Goodwill & Intangible Assets

$8,006,000 (-42.14%)

$13,838,000 (-47.18%)

$26,197,000 (38.71%)

$18,886,000 (24.68%)

Shareholders Equity

$4,972,000 (-60.81%)

$12,688,000 (-41.88%)

$21,831,000 (-14.10%)

$25,414,000 (-1.85%)

Property Plant & Equipment Net

$11,325,000 (-8.70%)

$12,404,000 (46.39%)

$8,473,000 (12.66%)

$7,521,000 (15.41%)

Cash & Equivalents

$8,595,000 (5.88%)

$8,118,000 (19.47%)

$6,795,000 (-46.01%)

$12,586,000 (-30.51%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$2,594,000 (-2.92%)

$2,672,000 (-13.58%)

$3,092,000 (-16.09%)

$3,685,000 (60.50%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$2,246,000 (-15.97%)

$2,673,000 (-51.81%)

$5,547,000 (58.99%)

$3,489,000 (1.31%)

Trade & Non-Trade Receivables

$5,253,000 (18.31%)

$4,440,000 (-0.69%)

$4,471,000 (30.24%)

$3,433,000 (16.61%)

Trade & Non-Trade Payables

$2,433,000 (-27.22%)

$3,343,000 (-2.39%)

$3,425,000 (21.37%)

$2,822,000 (2.10%)

Accumulated Retained Earnings (Deficit)

-$248,144,000 (-4.24%)

-$238,058,000 (-4.77%)

-$227,228,000 (-2.50%)

-$221,679,000 (-1.24%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$186,000 (-39.22%)

$306,000 (15.04%)

$266,000 (4.72%)

Total Debt

$16,439,000 (5.16%)

$15,633,000 (85.20%)

$8,441,000 (5.13%)

$8,029,000 (-26.22%)

Debt Current

$328,000 (-6.82%)

$352,000 (-0.85%)

$355,000 (11.64%)

$318,000 (-96.51%)

Debt Non-Current

$16,111,000 (5.43%)

$15,281,000 (88.98%)

$8,086,000 (4.86%)

$7,711,000 (338.13%)

Total Liabilities

$31,185,000 (6.33%)

$29,328,000 (-3.66%)

$30,441,000 (43.73%)

$21,179,000 (1.40%)

Liabilities Current

$14,625,000 (20.13%)

$12,174,000 (-9.33%)

$13,426,000 (4.87%)

$12,802,000 (-32.04%)

Liabilities Non-Current

$16,560,000 (-3.46%)

$17,154,000 (0.82%)

$17,015,000 (103.12%)

$8,377,000 (309.03%)

SSKN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$33,562,000 (0.61%)

$33,358,000 (-7.75%)

$36,161,000 (20.63%)

$29,977,000 (29.83%)

Cost of Revenue

$14,481,000 (-2.79%)

$14,897,000 (3.50%)

$14,393,000 (42.13%)

$10,127,000 (13.08%)

Selling General & Administrative Expense

$23,592,000 (0.55%)

$23,464,000 (-7.58%)

$25,388,000 (11.26%)

$22,818,000 (34.73%)

Research & Development Expense

$883,000 (-32.95%)

$1,317,000 (27.99%)

$1,029,000 (-28.24%)

$1,434,000 (12.56%)

Operating Expenses

$28,336,000 (4.70%)

$27,065,000 (2.45%)

$26,417,000 (8.93%)

$24,252,000 (33.18%)

Interest Expense

$2,107,000 (28.48%)

$1,640,000 (77.11%)

$926,000 (194.90%)

$314,000 (48.82%)

Income Tax Expense

-$170,000 (-84.78%)

-$92,000 (-246.03%)

$63,000 (85.29%)

$34,000 (-87.64%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$10,086,000 (6.87%)

-$10,830,000 (-95.17%)

-$5,549,000 (-105.06%)

-$2,706,000 (38.67%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$10,086,000 (6.87%)

-$10,830,000 (-95.17%)

-$5,549,000 (-105.06%)

-$2,706,000 (38.42%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$10,086,000 (6.87%)

-$10,830,000 (-95.17%)

-$5,549,000 (-105.06%)

-$2,706,000 (38.42%)

Weighted Average Shares

$3,807,186 (-89.10%)

$34,920,291 (0.60%)

$34,712,246 (1.94%)

$34,050,274 (1.31%)

Weighted Average Shares Diluted

$3,807,186 (-89.10%)

$34,920,291 (0.60%)

$34,712,246 (1.94%)

$34,050,274 (1.31%)

Earning Before Interest & Taxes (EBIT)

-$8,149,000 (12.21%)

-$9,282,000 (-103.55%)

-$4,560,000 (-93.38%)

-$2,358,000 (39.66%)

Gross Profit

$19,081,000 (3.36%)

$18,461,000 (-15.19%)

$21,768,000 (9.66%)

$19,850,000 (40.44%)

Operating Income

-$9,255,000 (-7.57%)

-$8,604,000 (-85.07%)

-$4,649,000 (-5.61%)

-$4,402,000 (-8.00%)

SSKN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$1,636,000 (67.40%)

-$5,019,000 (-19.99%)

-$4,183,000 (41.30%)

-$7,126,000 (-230.06%)

Net Cash Flow from Financing

$1,925,000 (-71.94%)

$6,861,000 (1472.20%)

-$500,000 (-643.48%)

$92,000 (-96.39%)

Net Cash Flow from Operations

$188,000 (136.22%)

-$519,000 (53.16%)

-$1,108,000 (-173.47%)

$1,508,000 (-28.05%)

Net Cash Flow / Change in Cash & Cash Equivalents

$477,000 (-63.95%)

$1,323,000 (122.85%)

-$5,791,000 (-4.80%)

-$5,526,000 (-322.55%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

-$631,000 (81.83%)

-$3,473,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$1,636,000 (67.40%)

-$5,019,000 (-41.30%)

-$3,552,000 (2.76%)

-$3,653,000 (-69.20%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$6,903,000 (0%)

$0 (0%)

$92,000 (-96.36%)

Issuance (Purchase) of Equity Shares

$1,943,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$427,000 (-67.23%)

$1,303,000 (-11.12%)

$1,466,000 (-10.77%)

$1,643,000 (0.61%)

Depreciation Amortization & Accretion

$5,307,000 (-10.08%)

$5,902,000 (3.76%)

$5,688,000 (39.21%)

$4,086,000 (4.47%)

SSKN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

56.90% (2.89%)

55.30% (-8.14%)

60.20% (-9.06%)

66.20% (8.17%)

Profit Margin

-30.10% (7.38%)

-32.50% (-112.42%)

-15.30% (-70.00%)

-9.00% (52.63%)

EBITDA Margin

-8.50% (15.84%)

-10.10% (-425.81%)

3.10% (-46.55%)

5.80% (0%)

Return on Average Equity (ROAE)

-121.40% (-82.56%)

-66.50% (-169.23%)

-24.70% (-130.84%)

-10.70% (35.15%)

Return on Average Assets (ROAA)

-25.90% (-15.63%)

-22.40% (-115.38%)

-10.40% (-76.27%)

-5.90% (37.23%)

Return on Sales (ROS)

-24.30% (12.59%)

-27.80% (-120.63%)

-12.60% (-59.49%)

-7.90% (53.25%)

Return on Invested Capital (ROIC)

-35.60% (19.46%)

-44.20% (-8.60%)

-40.70% (-26.01%)

-32.30% (52.36%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.1 (38.14%)

-1.77 (64.05%)

-4.94 (73.03%)

-18.31 (-58.71%)

Price to Sales Ratio (P/S)

0.33 (-42.71%)

0.58 (-24.01%)

0.76 (-54.45%)

1.66 (-23.77%)

Price to Book Ratio (P/B)

2.44 (60.59%)

1.52 (20.92%)

1.26 (-36.55%)

1.98 (1.28%)

Debt to Equity Ratio (D/E)

6.27 (171.40%)

2.31 (65.78%)

1.39 (67.35%)

0.83 (3.22%)

Earnings Per Share (EPS)

-2.65 (-754.84%)

-0.31 (-93.75%)

-0.16 (-100.00%)

-0.08 (38.46%)

Sales Per Share (SPS)

8.81 (823.04%)

0.95 (-8.35%)

1.04 (18.41%)

0.88 (28.09%)

Free Cash Flow Per Share (FCFPS)

-0.38 (-138.99%)

-0.16 (-18.66%)

-0.13 (-112.70%)

-0.06 (-3050.00%)

Book Value Per Share (BVPS)

1.31 (259.78%)

0.36 (-42.29%)

0.63 (-15.68%)

0.75 (-3.12%)

Tangible Assets Book Value Per Share (TABVPS)

7.39 (816.23%)

0.81 (7.46%)

0.75 (-7.74%)

0.81 (-13.50%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (33.33%)

-3 (50.00%)

-6 (68.42%)

-19 (-72.73%)

Enterprise Value Over EBITDA (EV/EBITDA)

-7.11 (9.32%)

-7.84 (-132.81%)

23.91 (-8.94%)

26.26 (-99.82%)

Asset Turnover

0.86 (24.96%)

0.69 (2.07%)

0.68 (3.69%)

0.65 (31.25%)

Current Ratio

1.14 (-11.12%)

1.28 (-2.07%)

1.3 (-16.41%)

1.56 (18.36%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$1,448,000 (73.85%)

-$5,538,000 (-18.84%)

-$4,660,000 (-117.25%)

-$2,145,000 (-3304.76%)

Enterprise Value (EV)

$20,219,079 (-23.75%)

$26,517,363 (-1.70%)

$26,974,679 (-40.56%)

$45,383,255 (5.14%)

Earnings Before Tax (EBT)

-$10,256,000 (6.10%)

-$10,922,000 (-99.09%)

-$5,486,000 (-105.31%)

-$2,672,000 (35.13%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$2,842,000 (15.92%)

-$3,380,000 (-399.65%)

$1,128,000 (-34.72%)

$1,728,000 (57500.00%)

Invested Capital

$21,370,000 (-9.14%)

$23,519,000 (64.53%)

$14,295,000 (38.14%)

$10,348,000 (86.05%)

Working Capital

$1,970,000 (-41.53%)

$3,369,000 (-17.39%)

$4,078,000 (-43.11%)

$7,168,000 (19.61%)

Tangible Asset Value

$28,151,000 (-0.10%)

$28,178,000 (8.07%)

$26,075,000 (-5.89%)

$27,707,000 (-12.40%)

Market Capitalization

$12,138,079 (-37.04%)

$19,280,363 (-29.72%)

$27,434,679 (-45.51%)

$50,344,255 (-0.61%)

Average Equity

$8,310,750 (-48.94%)

$16,277,750 (-27.45%)

$22,437,750 (-11.60%)

$25,383,000 (-4.79%)

Average Assets

$38,997,750 (-19.40%)

$48,384,000 (-9.64%)

$53,545,250 (16.34%)

$46,026,000 (-1.07%)

Invested Capital Average

$22,906,250 (9.10%)

$20,995,000 (87.43%)

$11,201,750 (53.58%)

$7,293,750 (26.59%)

Shares

4,171,161 (-88.10%)

35,048,833 (0.94%)

34,723,046 (1.04%)

34,364,679 (1.76%)